您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Edicotinib
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Edicotinib
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Edicotinib图片
CAS NO:1142363-52-7
包装与价格:
包装价格(元)
10 mM * 1 mL in DMSO电议
5mg电议
10mg电议
25mg电议
50mg电议
100mg电议
200mg电议
500mg电议

产品名称
JNJ-40346527
JNJ-527
产品介绍
Edicotinib (JNJ-40346527) 是一种有效的、选择性的、具有血脑通透性和口服活性CSF-1R抑制剂,IC50 为 3.2 nM。Edicotinib 对 KIT 和 FLT3 的抑制作用较小,IC50 值分别为 20 nM 和 190 nM。Edicotinib 抑制小胶质细胞的扩张,减弱小胶质细胞的增殖和神经退行性变。Edicotinib 可以用于阿尔茨海默病和类风湿性关节炎的研究。
生物活性

Edicotinib (JNJ-40346527) is a potent, selective, brain penetrant and orally active colony-stimulating factor-1 receptor (CSF-1R) inhibitor with anIC50of 3.2 nM. Edicotinib exhibits less inhibitory effects on KIT andFLT3withIC50values of 20 nM and 190 nM, respectively[1]. Edicotinib limits microglial expansion and attenuates microglial proliferation and neurodegeneration in mice. Edicotinib has the potential for Alzheimer’s disease and rheumatoid arthritis research[1][2].

IC50& Target

IC50: 3.2 nM (CSF-1R)[1]
20 nM (KIT); 190 nM (FLT3)[2]

体外研究
(In Vitro)

Edicotinib (0.1 nM-1μM; 24 hours) Leads to a dose-dependent decrease of CSF1R activation and a concurrent reduction of ERK1 and ERK2 phosphorylation. The dose response curve shows the effect of JNJ-527 on CSF1R and ERK1/2, and the IC50values are 18.6 nM and 22.5 nM for CSF1R and ERK1/2, respectively[1].

Western Blot Analysis[1]

Cell Line:N13 microglial cells
Concentration:0.1 nM, 1 nM, 10 nM, 100 nM, 1000 nM
Incubation Time:24 hours
Result:Prevented CSF1R and ERK1/2 phosphorylation in N13 microglial cells
体内研究
(In Vivo)

Edicotinib (oral gavage; 3, 10, 30 and 100 mg/kg; 5 days) significantly inhibits microglial proliferation in ME7 mice. It diminishes the number of microglia (total CD45+CD11b+cells) only at the highest dose tested of 100 mg/kg, and JNJ-527 depletes up to 50% of patrolling blood monocytes at every dose tested (CD45+CD11bhighLy6Cintermediate/lowcells) with only a tendency for a reduction in the proportion of inflammatory monocytes (Ly6C high cells) at 100 mg/kg[1].
Edicotinib exhibits a good pharmacokinetic/pharmacodynamics (PK/PD) profile, the microglial proliferation data shows an EC50of 196/ml and 69 ng/g calculated from plasmatic and brain compound concentration, respectively[1].
Edicotinib (oral gavage; 30 mg/kg; 33 days) significantly reduces the density of microglia in CA1 of the hippocampus of ME7-prion mice (PU.1+cells) by up to 30%. And the expression of IL-1β is also reduced,but not other inflammatory cytokines[1].

Animal Model:C57BL/6 J (Harlan) mice[1]
Dosage:3, 10, 30 and 100 mg/kg; 5 days
Administration:Oral gavage
Result:Did not affect microglial numbers when administered under 100 mg/kg.
Animal Model:C57BL/6 J (Harlan) mice[1]
Dosage:30 mg/kg; 33 days
Administration:Oral gavage
Result:Limited microglial expansion and attenuated behavioural deficits in ME7-prion mice.
Clinical Trial
分子量

461.60

性状

Solid

Formula

C27H35N5O2

CAS 号

1142363-52-7

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式
Powder-20°C3 years
4°C2 years
In solvent-80°C6 months
-20°C1 month
溶解性数据
In Vitro: 

DMSO : 16.67 mg/mL(36.11 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM2.1664 mL10.8319 mL21.6638 mL
5 mM0.4333 mL2.1664 mL4.3328 mL
10 mM0.2166 mL1.0832 mL2.1664 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: 17% Polyethylene glycol 12-hydroxystearate in saline

    Solubility: 10 mg/mL (21.66 mM); Suspended solution; Need ultrasonic

  • 2.

    请依序添加每种溶剂: 10% DMSO    40%PEG300   5%Tween-80   45% saline

    Solubility: ≥ 1.67 mg/mL (3.62 mM); Clear solution

    此方案可获得 ≥ 1.67 mg/mL (3.62 mM,饱和度未知) 的澄清溶液。

    以 1 mL 工作液为例,取 100 μL 16.7 mg/mL 的澄清 DMSO 储备液加到 400 μL PEG300 中,混合均匀;向上述体系中加入50 μL Tween-80,混合均匀;然后继续加入 450 μL生理盐水定容至 1 mL。

    将 0.9 g 氯化钠,完全溶解于 100 mL ddH2O 中,得到澄清透明的生理盐水溶液
  • 3.

    请依序添加每种溶剂: 10% DMSO    90%corn oil

    Solubility: ≥ 1.67 mg/mL (3.62 mM); Clear solution

    此方案可获得 ≥ 1.67 mg/mL (3.62 mM,饱和度未知) 的澄清溶液,此方案不适用于实验周期在半个月以上的实验。

    以 1 mL 工作液为例,取 100 μL 16.7 mg/mL 的澄清 DMSO 储备液加到 900 μL玉米油中,混合均匀。

*以上所有助溶剂都可在本网站选购。